Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opgen Inc (OPGN)

Opgen Inc (OPGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,018
  • Shares Outstanding, K 46,558
  • Annual Sales, $ 4,310 K
  • Annual Income, $ -34,810 K
  • 60-Month Beta -0.50
  • Price/Sales 4.20
  • Price/Cash Flow N/A
  • Price/Book 0.53
Trade OPGN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.85
  • Most Recent Earnings -0.15 on 05/12/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +21.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3100 +24.68%
on 05/16/22
0.6882 -43.84%
on 04/25/22
-0.2535 (-39.61%)
since 04/22/22
3-Month
0.3100 +24.68%
on 05/16/22
0.9200 -57.99%
on 03/14/22
-0.4386 (-53.16%)
since 02/23/22
52-Week
0.3100 +24.68%
on 05/16/22
3.7200 -89.61%
on 09/03/21
-1.6835 (-81.33%)
since 05/21/21

Most Recent Stories

More News
OpGen, Inc. (OPGN) Reports Q1 Loss, Lags Revenue Estimates

OpGen, Inc. (OPGN) delivered earnings and revenue surprises of 6.25% and 55.24%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OPGN : 0.3865 (-0.13%)
LFMD : 2.18 (+6.34%)
OpGen Reports First Quarter 2022 Financial Results and Provides Business Update

Total Q1 2022 revenues of $0.5 millionCash position of approximately $30.7 million to reach into Q1-2023 Management conference call scheduled for May 12,...

OPGN : 0.3865 (-0.13%)
Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates

Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of -31.58% and 2.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

BDSX : 1.4500 (-2.03%)
OPGN : 0.3865 (-0.13%)
OpGen to Provide Business Update and Financial Results for the First Quarter 2022 on May 12th at 4:30 p.m. Eastern Time

ROCKVILLE, Md., April 28, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a...

OPGN : 0.3865 (-0.13%)
OpGen’s Subsidiary Curetis and European Investment Bank Plan to Restructure Debt Repayment

ROCKVILLE, Md., April 25, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular...

OPGN : 0.3865 (-0.13%)
OpGen’s Subsidiary Ares Genetics Commercially Launches New Sequencing and Analysis Services Globally

New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolates...

OPGN : 0.3865 (-0.13%)
OpGen’s subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)

Extended existing master services agreement with Sandoz, to develop digital platform for development and life cycle management of antibiotics, to January...

OPGN : 0.3865 (-0.13%)
OpGen Announces Interim Analysis Results from Clinical Trial for Unyvero Urinary Tract Infection Panel

Interim analysis performed with initial 150 U.S. patient samples enrolled in its prospective multicenter trial for the Unyvero UTI panel - Clinical Trial...

OPGN : 0.3865 (-0.13%)
OpGen, Inc. (OPGN) Reports Q4 Loss, Tops Revenue Estimates

OpGen, Inc. (OPGN) delivered earnings and revenue surprises of -118.75% and 1.86%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

OPGN : 0.3865 (-0.13%)
ICLR : 217.58 (+0.68%)
OpGen Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Total revenue for 2021 was approximately $4.3 millionStrong total cash position of approximately $36.1 million as of December 31, 2021, up significantly...

OPGN : 0.3865 (-0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.

See More

Key Turning Points

3rd Resistance Point 0.4023
2nd Resistance Point 0.3986
1st Resistance Point 0.3925
Last Price 0.3865
1st Support Level 0.3827
2nd Support Level 0.3790
3rd Support Level 0.3729

See More

52-Week High 3.7200
Fibonacci 61.8% 2.4174
Fibonacci 50% 2.0150
Fibonacci 38.2% 1.6126
Last Price 0.3865
52-Week Low 0.3100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar